CRSP Operating Cash Flow
Crispr Therapeutics Ag · Operating Cash Flow
CRSP Operating Cash Flow
Latest reported-$369.58Mperiod ending
CRSP Operating Cash Flow (-$4.79M → -$369.58M)
Annual operating cash flow
High-resolution chart · PNG
CRSP operating cash flow history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| -345,014,000 | |
| -142,774,000 | |
| -260,375,000 | |
| -495,741,000 | |
| 538,972,000 | |
| -238,366,000 | |
| 56,677,000 | |
| -96,239,000 | |
| -70,097,000 | |
| -55,310,000 | |
| 59,428,000 | |
| -4,793,000 |